Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Javier Sastre(Hospital Clínico San Carlos), Eduardo Díaz‐Rubio(Hospital Clínico San Carlos), Joan Maurel(Breast Cancer Research Foundation), Albert Abad, Enrique Aranda(Instituto Maimónides de Investigación Biomédica de Córdoba), Alfredo Carrato(Hospital General Universitario de Elche), I. Maestu(Hospital Clínico San Carlos), Silvia Gil(Hospital Clínico San Carlos), Antonio Antón(Hospital Universitario Miguel Servet), Eugenio Marcuello(Hospital de Sant Pau), Matilde Navarro, J. M. Vicent(Hospital Clínico San Carlos), Manuel Valladares(American Society of Clinical Oncology), B. Masutti(Hospital Clínico San Carlos)
Journal of Clinical Oncology
May 20, 2005
10.1200/jco.2005.03.004
Cited by 98

Related Papers

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
|The Lancet|2005|631
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
|Gut|2019|620
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
|The Lancet|2022|581
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
|Journal of Clinical Oncology|2005|454
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
|Annals of Oncology|2013|351